Date: Wednesday 3 October 2012
Venue: One Great George Street Conference Centre, London
Plenary Session 1
HCV mono-infection: when to treat and when to wait
Professor Stefan Zeuzem, J.W. Goethe University Hospital, Frankfurt, Germany
HIV/HCV co-infection: when to treat and when to wait
Dr Curtis Cooper, The Ottawa Hospital, Canada
Plenary Session 2
Pathogenesis of liver disease in HIV/HBV co-infection
Professor Sharon Lewin, Alfred Hospital and Monash University, Melbourne, Australia
Treating hepatitis C in patients with chronic renal disease
Dr Ashley Brown, Imperial College Healthcare NHS Trust, London
Debate
The motion: HIV-1-positive patients co-infected with hepatitis C should be excluded from liver transplant programmes
For the motion:
Professor John O'Grady, King's College Hospital, London
Against the motion:
Dr James O'Beirne, Royal Free Hospital, London
Plenary Session 3
The impact of viral resistance in the management of HCV with DAAs
Professor Stanislas Pol, University of Paris, France
Drug-drug interactions with new HCV drugs
Professor David Back, University of Liverpool
Difficult HIV/hepatitis co-infection SpR case presentation session
A case of complications
Dr Katharine Cartwright, Leicester Royal Infirmary
First do no harm...
Dr Emma O'Cofaigh, Leeds Teaching Hospitals Trust
HCV or not HCV, that is the question
Dr Beth White, NHS Greater Glasgow and Clyde